NCT04545762 2026-01-14Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin LymphomaUniversity of California, San FranciscoPhase 1 Recruiting36 enrolled
NCT05621096 2025-09-25Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin LymphomaUniversity of NebraskaPhase 1 Active not recruiting33 enrolled